The Emerging Role of NOTCH3 Receptor Signalling in Human Lung Diseases

Overview

Journal Expert Rev Mol Med

Specialty General Medicine

Date 2022 Sep 2

PMID 36052538

Authors

Manish Bodas

Bharathiraja Subramaniyan

Harry Karmouty-Quintana

Peter F Vitiello

Matthew S Walters

Affiliations

Soon will be listed here.

Abstract

The mammalian respiratory system or lung is a tree-like branching structure, and the main site of gas exchange with the external environment. Structurally, the lung is broadly classified into the proximal (or conducting) airways and the distal alveolar region, where the gas exchange occurs. In parallel with the respiratory tree, the pulmonary vasculature starts with large pulmonary arteries that subdivide rapidly ending in capillaries adjacent to alveolar structures to enable gas exchange. The NOTCH signalling pathway plays an important role in lung development, differentiation and regeneration post-injury. Signalling via the NOTCH pathway is mediated through activation of four NOTCH receptors (NOTCH1-4), with each receptor capable of regulating unique biological processes. Dysregulation of the NOTCH pathway has been associated with development and pathophysiology of multiple adult acute and chronic lung diseases. This includes accumulating evidence that alteration of NOTCH3 signalling plays an important role in the development and pathogenesis of chronic obstructive pulmonary disease, lung cancer, asthma, idiopathic pulmonary fibrosis and pulmonary arterial hypertension. Herein, we provide a comprehensive summary of the role of NOTCH3 signalling in regulating repair/regeneration of the adult lung, its association with development of lung disease and potential therapeutic strategies to target its signalling activity.

Citing Articles

Screening COPD-Related Biomarkers and Traditional Chinese Medicine Prediction Based on Bioinformatics and Machine Learning.

Cao Z, Zhao S, Hu S, Wu T, Sun F, Shi L Int J Chron Obstruct Pulmon Dis. 2024; 19:2073-2095.

PMID: 39346628 PMC: 11438478. DOI: 10.2147/COPD.S476808.

The disruptive effects of COPD exacerbation-associated factors on epithelial repair responses.

Kortekaas R, Geillinger-Kastle K, Fuentes-Mateos R, van Orsoy R, Al-Alyan N, Burgess J Front Immunol. 2024; 15:1346491.

PMID: 38911863 PMC: 11193328. DOI: 10.3389/fimmu.2024.1346491.

Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again.

Bahi M, Li C, Wang G, Korman B Int J Mol Sci. 2024; 25(9).

PMID: 38731946 PMC: 11084945. DOI: 10.3390/ijms25094728.

Examining the contribution of Notch signaling to lung disease development.

Antar S, ElMahdy M, Darwish A Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6337-6349.

PMID: 38652281 DOI: 10.1007/s00210-024-03105-8.

Myofibrillogenesis Regulator-1 Regulates the Ubiquitin Lysosomal Pathway of Notch3 Intracellular Domain Through E3 Ubiquitin-Protein Ligase Itchy Homolog in the Metastasis of Non-Small Cell Lung Cancer.

Zhao W, Li Y, Cheng H, Wang M, Zhang Z, Cai M Adv Sci (Weinh). 2024; 11(15):e2306472.

PMID: 38342606 PMC: 11022719. DOI: 10.1002/advs.202306472.

References

Chambers R, Mercer P . Mechanisms of alveolar epithelial injury, repair, and fibrosis. Ann Am Thorac Soc. 2015; 12 Suppl 1:S16-20. PMC: 4430974. DOI: 10.1513/AnnalsATS.201410-448MG. View

Kalil A, Thomas P . Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care. 2019; 23(1):258. PMC: 6642581. DOI: 10.1186/s13054-019-2539-x. View

Li C, Sheng A, Jia X, Zeng Z, Zhang X, Zhao W . Th17/Treg dysregulation in allergic asthmatic children is associated with elevated notch expression. J Asthma. 2017; 55(1):1-7. DOI: 10.1080/02770903.2016.1266494. View

Sethi S . Infection as a comorbidity of COPD. Eur Respir J. 2010; 35(6):1209-15. DOI: 10.1183/09031936.00081409. View

Pak O, Aldashev A, Welsh D, Peacock A . The effects of hypoxia on the cells of the pulmonary vasculature. Eur Respir J. 2007; 30(2):364-72. DOI: 10.1183/09031936.00128706. View

Cook N, Basu B, Smith D, Gopinathan A, Evans J, Steward W . A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. Br J Cancer. 2018; 118(6):793-801. PMC: 5877439. DOI: 10.1038/bjc.2017.495. View

Reid A, Nichol K, Veerati P, Moheimani F, Kicic A, Stick S . Blocking Notch3 Signaling Abolishes MUC5AC Production in Airway Epithelial Cells from Individuals with Asthma. Am J Respir Cell Mol Biol. 2020; 62(4):513-523. DOI: 10.1165/rcmb.2019-0069OC. View

. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020; 8(6):585-596. PMC: 7284317. DOI: 10.1016/S2213-2600(20)30105-3. View

Gerayeli F, Milne S, Cheung C, Li X, Yang C, Tam A . COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine. 2021; 33:100789. PMC: 7971471. DOI: 10.1016/j.eclinm.2021.100789. View

10.

Cafferkey J, Coultas J, Mallia P . Human rhinovirus infection and COPD: role in exacerbations and potential for therapeutic targets. Expert Rev Respir Med. 2020; 14(8):777-789. DOI: 10.1080/17476348.2020.1764354. View

11.

Sakai L, Keene D, Renard M, De Backer J . FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders. Gene. 2016; 591(1):279-291. PMC: 6639799. DOI: 10.1016/j.gene.2016.07.033. View

12.

Zong D, Ouyang R, Li J, Chen Y, Chen P . Notch signaling in lung diseases: focus on Notch1 and Notch3. Ther Adv Respir Dis. 2016; 10(5):468-84. PMC: 5933616. DOI: 10.1177/1753465816654873. View

13.

Jespersen K, Liu Z, Li C, Harding P, Sestak K, Batra R . Enhanced Notch3 signaling contributes to pulmonary emphysema in a Murine Model of Marfan syndrome. Sci Rep. 2020; 10(1):10949. PMC: 7331498. DOI: 10.1038/s41598-020-67941-3. View

14.

Liao K, Hung C, Shu C, Lee H, Wei Y . Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Small Cell Lung Cancer. Int J Chron Obstruct Pulmon Dis. 2021; 16:3255-3262. PMC: 8645948. DOI: 10.2147/COPD.S328938. View

15.

Kainulainen K, Karttunen L, Puhakka L, Sakai L, Peltonen L . Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nat Genet. 1994; 6(1):64-9. DOI: 10.1038/ng0194-64. View

16.

de Andrade J, Owens G, Tolle L . Idiopathic pulmonary fibrosis: exploring the clinical and economic implications of the evolving treatment landscape. Am J Manag Care. 2021; 27(7 Suppl):S131-S137. DOI: 10.37765/ajmc.2021.88655. View

17.

Parekh K, Nawroth J, Pai A, Busch S, Senger C, Ryan A . Stem cells and lung regeneration. Am J Physiol Cell Physiol. 2020; 319(4):C675-C693. PMC: 7654650. DOI: 10.1152/ajpcell.00036.2020. View

18.

Uriarte J, Meirelles T, Gorbenko Del Blanco D, Nonaka P, Campillo N, Sarri E . Early Impairment of Lung Mechanics in a Murine Model of Marfan Syndrome. PLoS One. 2016; 11(3):e0152124. PMC: 4803219. DOI: 10.1371/journal.pone.0152124. View

19.

Wang J, Yan X, Feng W, Wang Q, Shi W, Chai L . S1P induces proliferation of pulmonary artery smooth muscle cells by promoting YAP-induced Notch3 expression and activation. J Biol Chem. 2021; 296:100599. PMC: 8094894. DOI: 10.1016/j.jbc.2021.100599. View

20.

Basil M, Katzen J, Engler A, Guo M, Herriges M, Kathiriya J . The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future. Cell Stem Cell. 2020; 26(4):482-502. PMC: 7128675. DOI: 10.1016/j.stem.2020.03.009. View